BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING AGENT IN TREATMENT OF PARKINSON'S DISEASE
- 1 March 1979
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 313 (8116), 570-572
- https://doi.org/10.1016/s0140-6736(79)91003-1
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Onset and End-of-Dose Levodopa-Induced DyskinesiasArchives of Neurology, 1978
- LONG-TERM TREATMENT OF PARKINSONISM WITH BROMOCRIPTINEThe Lancet, 1978
- Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1977
- Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1977
- Treatment of Parkinson's Disease with BromocriptineNew England Journal of Medicine, 1976
- THE CARDIOVASCULAR EFFECTS OF BROMOCRIPTINE IN PARKINSONISMBritish Journal of Clinical Pharmacology, 1976
- Studies with bromocriptine Part 2. Double‐blind comparison with levodopa in idiopathic parkinsonismNeurology, 1976
- IDIOPATHIC PARKINSONISM TREATED WITH BROMOCREPTINEThe Lancet, 1975
- Bromocriptine in ParkinsonismBMJ, 1974
- ParkinsonismNeurology, 1967